# Lazurite Inc. – FDA Inspection, Feb 7, 2025

Source: https://www.keypedia.com/records/fda_inspections/lazurite-inc/373a5bbf-d1cb-40f3-af16-f8d4e8c790eb
Source feed: FDA_Inspections

> FDA inspection 1260228 of Lazurite Inc., February 07, 2025. Classification: No Action Indicated (NAI). 5 citations under 21 CFR part 820. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260228
- Company Name: Lazurite Inc.
- Inspection Date: 2025-02-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Cincinnati District Office
- Citation Count: 5

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/laureen-m-geniusz/759a858e-e3f3-4c48-8194-9804c7ab2a7b)

Company: https://www.keypedia.com/companies/lazurite-inc/e8bc21ea-a163-4af7-bd27-00a071256f5e

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22
